CANNABIDIOL (CBD) Pre-Review Report - WHO
CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2 Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017
Download CANNABIDIOL (CBD) Pre-Review Report - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
WEEKLY UPDATE – April 20, 2018 - floridahealth.gov
www.floridahealth.gov*Note, not all patients entered into the medical marijuana use registry apply for medical marijuana use identification cards. WEEKLY UPDATE – April 20, 2018
Update of Cannabis and its medical use - WHO
www.who.int37th ECDD (2015) Agenda item 6.2 Cannabis Page 3 of 41 Preface This update of cannabis and its medical use was commissioned by the Secretariat of the Expert
MEDICAL MARIJUANA ACCESS IN THE UNITED …
american-safe-access.s3.amazonaws.comamericansforsafeaccess.org medical marijuana access in the united states medical marijuana access in the united states a patient-focused analysis of the
NOTICE: STATE PROPOSALS - michigan.gov
www.michigan.govUnited States that allows the medical use of marihuana by a visiting qualifying patient, or to allow a person to assist with a visiting qualifying patient's medical
Applicant Drug Policy Statement - United States …
www.secretservice.govSSF 4018 (Rev. 04/2017) Page 1 of 5 Department of Homeland Security UNITED STATES SECRET SERVICE APPLICANT DRUG POLICY STATEMENT The United States Secret Service (USSS) is committed to a drug-free workplace.